Approval of new CAR-T may have ‘immediate impact’ on treatment of large B-cell lymphoma

SCCA's David Maloney, MD, PhD, discussed clinical trials and new CAR T-cell therapies for patients with large B-cell lymphoma.

Read the Healio Article